ClinicalTrials.Veeva

Menu

A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.

T

Tianshu Liu

Status

Completed

Conditions

Locally Advanced Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02192983
zswy002

Details and patient eligibility

About

This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.

Enrollment

242 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more than 2 regional bulky lymph nodes macroscopic tumor type is either the Borrmann type 4 or large type 3 tumor invades adjacent structures (T4b)

Exclusion criteria

  • peritoneal metastasis confirmed by CT scan lung metastasis, liver metastasis, pleural effusion, and/or other distant metastasis

Trial design

242 participants in 1 patient group

chemotherapy regimen
Description:
those with XELOX regimen and those with EOX regimen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems